Australian government to subsidize Visanne, making it more affordable for endometriosis sufferers.

The Australian government will subsidize Visanne (dienogest) for the first time in 30 years, making it more affordable for the over one million Australians suffering from endometriosis. The daily tablet helps reduce symptoms like severe period pain and heavy bleeding by suppressing abnormal tissue growth. Previously costing around $750 a year, the subsidy is part of a $107 million investment in endometriosis support.

November 30, 2024
22 Articles